SUPN - Supernus Pharmaceuticals Inc. (SUPN) CEO Jack Khattar on Q1 2022 Results - Earnings Call Transcript

Supernus Pharmaceuticals, Inc. (SUPN) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Peter Vozzo - Westwicke, Investor Relations Jack Khattar - Chief Executive Officer Tim Dec - Chief Financial Officer Conference Call Participants David Amsellem - Piper Sandler Jack Padovano - Stifel Presentation Operator Good afternoon, and welcome to Supernus Pharmaceuticals' First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference call is being recorded. And I would now like to turn the call over to Peter Vozzo of Westwicke, Investor Relations representative for Supernus Pharmaceuticals. Sir, you may begin. Peter Vozzo Thank you, Chris. Good afternoon, everyone and thank you for joining us today for Supernus Pharmaceuticals' first quarter 2022 financial results conference call. Today after the close of the market, the company issued a press release announcing these results.

For further details see:

Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2022 Results - Earnings Call Transcript